Tag Archives: Cannabidiol Research Expansion Act

Tillis Co-Sponsors Legislation to Expand Research into Medical Benefits of Cannabidiol

RALEIGH, N.C., June 5, 2017 /Weed Wire/ – U.S. Senator Thom Tillis (R-NC) recently co-sponsored the Cannabidiol Research Expansion Act, a bill to support research initiatives on the potential benefits of substances such as cannabidiol (CBD) that are derived from marijuana.

Federal Legislation: Cannabidiol Research Expansion Act Introduced

Federal Legislation: Cannabidiol Research Expansion Act Introduced

On May 25, 2017, Sens. Dianne Feinstein, D-Calif., and Chuck Grassley, R-Iowa, announced that they had introduced the Cannabidiol Research Expansion Act, a bill that would ask the Attorney General to reconsider whether cannabidiol should be scheduled under the Controlled Substances Act and expand research opportunities as a means of determining the medical efficacy of cannabidiol and marijuana in the treatment of serious medical conditions.

Feinstein, Grassley Introduce Bill to Expand Research into Medical Benefits of Cannabidiol and Marijuana

WASHINGTON, May 25, 2017 /Weed Wire/ — Senators Dianne Feinstein (D-Calif.) and Chuck Grassley (R-Iowa), leaders of the Senate Caucus on International Narcotics Control, today introduced the Cannabidiol Research Expansion Act, a bill to support research initiatives on the potential benefits of substances such as cannabidiol (CBD) that are derived from marijuana.

Americans for Safe Access Opioid Veterans Senate Committee

Senators Grassley and Feinstein Introduce Bill to Exempt Certain Medical Cannabis Patients From Federal Prosecution

WASHINGTON, July 18, 2016 /Weed Wire/ — Today, the Cannabidiol Research Expansion Act (S. 3269) was introduced in the United States Senate, which would ease research barriers and create exemptions from federal law for certain medical cannabis patients.


Top